Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2017-11-02 Interim / Quarterly Rep…
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Rapport financier semestriel
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Rapport Financier Semestriel 2017' (2017 Half-Year Financial Report) and contains comprehensive financial statements, including the 'Etat de la situation financière' (Statement of Financial Position), income statements, and management discussion and analysis for the period ending June 30, 2017. It is a full interim report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H2 2017
2017-11-02 French
Rapport financier annuel
Annual Report Classification · 100% confidence The document is titled 'Rapport Financier Annuel 2016' (Annual Financial Report 2016) for Mauna Kea Technologies. It contains a comprehensive summary, management reports (Rapport de gestion), consolidated financial statements (Comptes consolidés), annual accounts (Comptes annuels), and audit reports (Rapport des commissaires aux comptes). This structure is characteristic of a full Annual Report (10-K equivalent in the French market). FY 2016
2017-11-02 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated October 30, 2017, announcing that new data from the CONTACT study regarding Cellvizio for pancreatic cysts was presented at the United European Gastroenterology Week (UEGW) 2017 meeting. It details the study outcomes, mentions other presentations at the conference, and provides company contact information. This format—a news announcement about scientific/clinical data presentation, often issued by a medical device or pharmaceutical company—does not fit the specific regulatory filings like 10-K, IR, ER, or DEF 14A. It is a general corporate announcement regarding scientific progress and conference participation. Since it is not a specific regulatory filing, nor a transcript, nor a management discussion, the most appropriate general category for a corporate announcement that doesn't fit elsewhere is 'Regulatory Filings' (RNS), which serves as a broad category for miscellaneous corporate news releases that are not explicitly defined elsewhere.
2017-10-30 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Legal Proceedings Report Classification · 99% confidence The document is a press release dated October 30, 2017, announcing that new analysis from the CONTACT study regarding the Cellvizio device was presented at the European Congress of Gastroenterology (UEG Week 2017). It details scientific findings and mentions presentations and posters at a conference. This type of announcement, which communicates recent corporate or scientific news, typically falls under a general regulatory announcement or a specific investor relations communication. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific legal/management update, and it is primarily communicating scientific/business progress to investors, it best fits the 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially 'Investor Presentation' (IP) if it were the presentation itself, but here it is the *announcement* of the presentation. Given the context of a press release detailing scientific updates presented at a conference, RNS is the most appropriate general regulatory filing category for non-standard reports.
2017-10-30 French
Information financière trimestrielle / Information financière du troisième trimestre
Earnings Release Classification · 98% confidence The document is titled "MAUNA KEA TECHNOLOGIES ANNONCE SON CHIFFRE D'AFFAIRES DU 3e TRIMESTRE 2017" (Mauna Kea Technologies announces its third-quarter 2017 revenue). It contains detailed financial tables showing revenue figures for the third quarter (T3 2017) and the first nine months (9M 2017) compared to the previous year. It also mentions an upcoming conference call to discuss these results. This structure—announcing period-specific financial results with key figures and tables, but not being the full annual report (10-K) or a generic regulatory filing—strongly indicates an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it focuses specifically on the quarterly revenue announcement and includes details typical of an earnings report (sales breakdown, management commentary on results), it fits best as an Earnings Release (ER) or an Interim Report (IR). Given the explicit focus on the quarterly results announcement, 'ER' (Earnings Release) is highly appropriate, although 'IR' (Interim Report) is also plausible as it covers 9 months. However, the text reads like the initial press release summarizing the period's performance, which aligns perfectly with the definition of an Earnings Release (ER). The document length is substantial (12,929 chars), suggesting more than just a brief highlight, but the primary function is the announcement of the period's financial performance. Q3 2017
2017-10-19 French
Quarterly financial report / Third quarter financial report
Earnings Release Classification · 100% confidence The document is a press release titled 'MAUNA KEA TECHNOLOGIES REPORTS THIRD QUARTER 2017 SALES'. It provides a summary of financial performance, including sales figures, geographic breakdowns, and unit sales for the third quarter of 2017. While it contains financial data, it is structured as an initial announcement of quarterly results (key highlights) rather than a comprehensive interim financial report. According to the filing definitions, this fits the 'Earnings Release' (ER) category. Q3 2017
2017-10-19 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.